Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2025-05-08 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2024年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2024 Annual General Meeting Resolution Announcement" for Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the convening and attendance of the shareholders' meeting, the agenda items discussed, and the voting results on various proposals including the 2024 annual reports, financial statements, auditor appointment, remuneration plans, and dividend decisions. The document is a formal announcement of the resolutions passed at the annual general meeting (AGM), including voting outcomes and procedural compliance. It does not contain the full annual report or financial statements themselves but references where those reports can be found. The document length is about 5307 characters, which is consistent with an announcement rather than a full report. Therefore, this document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA), as it officially announces the results of shareholder votes at the AGM.
2025-05-08 Chinese
关于持股5%以上股东及其一致行动人权益变动触及1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding changes in shareholding by shareholders holding more than 5% of the company's shares. It details the reduction in shareholding percentages by specific shareholders and confirms that the changes do not affect control of the company or violate regulations. The document is titled as a '提示性公告' (prompting announcement) about shareholding changes touching the 1% threshold. It does not contain financial statements, management discussion, or detailed financial data. It is a notification of a major shareholding change, fitting the category of 'Major Shareholding Notification' (MRQ). The document length is short (1681 characters), consistent with an announcement rather than a full report.
2025-05-07 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by the company Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the unusual stock price movement over a specific recent period, the company's investigation into the causes, and a statement confirming no undisclosed material information affecting stock price. It also includes a risk warning to investors. The document is short (980 characters) and focuses on stock price abnormality and related disclosures, which fits the profile of a Regulatory Filing (RNS) rather than a full financial report or other specific filing types. There is no indication of an annual report, earnings release, or other detailed financial data. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-05-05 Chinese
关于产品取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the acquisition of a medical device registration certificate for a product called the Interference Electric Therapy Instrument. It details the certificate number, validity period, and the product's intended medical applications. The document discusses the impact of this registration on the company's financial status and business operations, emphasizing the product's market potential and risks. The document is relatively short (1530 characters) and serves as a formal announcement of a regulatory approval rather than a financial report or detailed operational report. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a report of voting results, board changes, or legal proceedings. It is a regulatory announcement about product certification and its implications. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-04-27 Chinese
第三届董事会第二十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 24th meeting of the third board of directors of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the meeting's time, place, attendance, and the approval of the company's 2025 first quarter report. However, the actual 2025 first quarter report is not included in this document; instead, it references that the report was disclosed separately on the Beijing Stock Exchange information disclosure platform (announcement number 2025-037). The document is short (942 characters) and serves as a meeting resolution announcement rather than the report itself. Therefore, it is best classified as a Regulatory Filing (RNS) because it does not contain substantive financial data or the full report but announces the board's approval of the report.
2025-04-27 Chinese
2025年一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "四川千里倍益康医疗科技股份有限公司 2025 年第一季度报告" which translates to "Sichuan Qianli Beiyikang Medical Technology Co., Ltd. 2025 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2025. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period January to March 2025. It is unaudited but contains substantive financial data and management commentary on financial results. This matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), and it is the report itself, not an announcement or certification. Therefore, the correct classification is IR with high confidence. Q1 2025
2025-04-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.